Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Dynamics analysis and optimal control of delayed SEIR model in COVID-19 epidemicJournal of inequalities and applications, 2024-12, Vol.2024 (1), p.66-37 [Peer Reviewed Journal]The Author(s) 2024 ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1025-5834 ;EISSN: 1029-242X ;DOI: 10.1186/s13660-024-03140-2Full text available |
|
2 |
Material Type: Newspaper Article
|
Xi Jinping’s Recipe for Total Control: An Army of Eyes and EarsNew York Times (Online), 2024-05-25Copyright 2024 The New York Times Company ;EISSN: 1553-8095Full text available |
|
3 |
Material Type: Article
|
United Kingdom Hedge Funds 22 May 24Industry SnapShots, 2024-05Copyright (c) 2024 Acquisdata Pty Ltd ;EISSN: 2203-2738Full text available |
|
4 |
Material Type: Newsletter Article
|
Shorepower Technologies Wins Two State of Washington Grants with project values totaling over $380,000Financial Services Monitor Worldwide, 20242022 Global Data Point. All Rights Reserved. Provided by SyndiGate Media Inc. (Syndigate.info).Digital Resources/Online E-Resources |
|
5 |
Material Type: Newsletter Article
|
Press Release: Shorepower Technologies Wins Two State of Washington Grants with project values totaling over $380,000Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 13, 2024Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Investigating the trend of demographic changes, mortality, clinical and paraclinical findings of patients hospitalized in the Corona ward, before and after the start of general vaccination of COVID-19BMC infectious diseases, 2024-05, Vol.24 (1), p.488-488 [Peer Reviewed Journal]2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 1471-2334 ;EISSN: 1471-2334 ;DOI: 10.1186/s12879-024-09279-z ;PMID: 38741059Full text available |
|
7 |
Material Type: Newsletter Article
|
Shorepower Technologies Wins Two State of Washington Grants with project values totaling over $380,000NASDAQ OMX's News Release Distribution Channel, 2024GlobeNewswire, Inc.Digital Resources/Online E-Resources |
|
8 |
Material Type: Web Resources
|
Newsfile Corp.: FansUnite to Report First Quarter Fiscal 2024 Financial Results and Host Earnings CallNewstex Finance & Accounting Blogs, 2024Copyright Newstex May 10, 2024Digital Resources/Online E-Resources |
|
9 |
Material Type: Newsletter Article
|
Press Release: Ducommun Incorporated Reports -2Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 8, 2024Digital Resources/Online E-Resources |
|
10 |
Material Type: Newsletter Article
|
Press Release: OraSure Reports Q1 '24 Revenue of -3Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 8, 2024Digital Resources/Online E-Resources |
|
11 |
Material Type: Newsletter Article
|
Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company ProgressBusiness Wire, 2024Copyright Business Wire 2024Digital Resources/Online E-Resources |
|
12 |
Material Type: Newsletter Article
|
Press Release: Chart Industries Reports First -2Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 3, 2024Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
Impact of an innovative bundled payment to TB health care providers in China: an economic simulation analysisBMC health services research, 2024-05, Vol.24 (1), p.577-577 [Peer Reviewed Journal]2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1472-6963 ;EISSN: 1472-6963 ;DOI: 10.1186/s12913-024-11034-8 ;PMID: 38702650Full text available |
|
14 |
Material Type: Article
|
Optimal Control for an Epidemic Model of COVID-19 with Time-Varying ParametersMathematics (Basel), 2024-05, Vol.12 (10), p.1484 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2227-7390 ;EISSN: 2227-7390 ;DOI: 10.3390/math12101484Full text available |
|
15 |
Material Type: Newsletter Article
|
BrightSpire Capital, Inc. Announces First Quarter 2024 Financial ResultsBusiness Wire, 2024Copyright Business Wire 2024Digital Resources/Online E-Resources |
|
16 |
Material Type: Newsletter Article
|
Press Release: BrightSpire Capital, Inc. Announces First Quarter 2024 Financial ResultsDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 1, 2024Digital Resources/Online E-Resources |
|
17 |
Material Type: Newsletter Article
|
Press Release: EnLink Midstream Reports First -2Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. Apr 30, 2024Digital Resources/Online E-Resources |
|
18 |
Material Type: Newsletter Article
|
Pension Administration Software Market to Reach USD 13 bn, Globally, by 2032, According to Allied Market ResearchM2 Banking & Credit News, 2024Copyright © M2 Communications, 2024Digital Resources/Online E-Resources |
|
19 |
Material Type: Newsletter Article
|
Pension Administration Software Market to Reach USD 13 bn, Globally, by 2032, According to Allied Market ResearchM2 EquityBites, 2024Copyright © M2 Communications, 2024Digital Resources/Online E-Resources |
|
20 |
Material Type: Newsletter Article
|
Press Release: Biogen Receives Positive CHMP Opinion for TOFIDENCE(TM) (tocilizumab), a Biosimilar Referencing ROACTEMRA(R)Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. Apr 25, 2024Digital Resources/Online E-Resources |